GELCLAIR® was approved by the FDA in 2001 and is specifically designed and approved for management and relief of pain in oral mucositis. It contains key ingredients that protect, hydrate and soothe the mouth and has a mild flavor. Download Gelclair Patient Brochure: GELCLAIR® was approved by the FDA in 2001 and is specifically designed and approved for management and relief of pain in oral mucositis. It contains key ingredients that protect, hydrate and soothe the mouth and has a mild flavor.
 
If you are receiving chemotherapy or radiation to the head and/or neck, you are at risk for oral mucositis. People who smoke, drink alcohol, don’t practice daily oral care, wear ill-fitting braces or dentures, and/or have dry mouth while receiving chemotherapy or radiation are at greater risk for oral mucositis Healthcare Professionals
  You are now entering the GELCLAIR® Health Care Professional website. This site is intended for U.S. health care professionals only. If you would like to continue, please click the link below.
 

Yes, I am a U.S. health care professional
ENTER Indications

or

Dosing Administration

Return to the GELCLAIR®  Patient Site
 
   

 

HOME - Health Care Professionals - Contact Us - Understanding Oral Mucositis - Reducing Signs and Symptoms of Oral Mucositis - Managing Oral Mucositis - Clinical Experience Indications - Dosing and Administration

© 2007 EKR Therapeutics, Inc. All rights reserved.
Web Site Privacy Policy
Marketed and distributed by: EKR Therapeutics, Inc., Cedar Knolls, NJ 07927 under license of Helsinn Healthcare SA, Lugano, Switzerland
GELCLAIR® is a registered trademark of Helsinn Healthcare SA, Lugano, Switzerland.